COMPETITOR PROFILING

The Competitive Edge: Data‑Driven Competitor
Profiling for Smarter APAC Peptide Growth

In a focused competitor profiling initiative, a peptide API manufacturer used deep dives into various contract manufacturers based in Asia-Pacific to optimize supply chain resilience and unlock more profitable deals across the region

Let's Talk

The Challenge

Evaluating Opportunities and Accelerate
Growth in APAC Peptide APIs

Incomplete Map of APAC
Peptide Manufacturers

The client, a global large‑sized peptide drug manufacturer, had only a partial understanding of the peptide API contract manufacturing capabilities in the APAC region. Further, they had limited visibility of new entrants who could offer significant future competition

Unclear View of Technical and
Regulatory Capabilities

While the client believed that APAC CMOs could support complex peptide programs, they did not have a structured view of which competitors truly specialized in advanced modifications and stringent regulatory compliance

Limited Visibility into Direct
Competitors in APAC

The client also lacked a view on which other firms were directly competing for similar contract manufacturing projects, customer base, key accounts and partnership opportunities

The Roots Way

How Roots Helped?

Roots Analysis designed a robust competitive analysis platform that integrated broad market research with targeted industry insights.

Identified Priority Peptide CMOs: We mapped the peptide API contract manufacturing (CMO) landscape across different countries in the APAC region through our internal knowledge base and additional targeted research. From this comprehensive list, we shortlisted priority manufacturers based on geography, scale of operations and existing relationships with global innovators, creating a clear view of the most relevant players for the client’s portfolio.

Developed In‑Depth Company Profiles:For each shortlisted CMO, we created a detailed profile covering company overview, facility locations, scale of operation, quality certifications and key service offerings. In addition, we compiled a concise financial and business overview for each player (revenue bands, segment focus, growth levers) and captured recent strategic initiatives, such as capacity expansions, new technology introductions, partnerships and M&A activity related to peptide APIs.

Delivered Insight-driven Strategies:Drawing on the above insights, we developed company‑specific SWOT studies and a competitive analysis that benchmarked each CMO against peers on the relative strengths and weaknesses. These insights were translated into actionable recommendations highlighting company specific peptide outsourcing trends in the region and outlining strategic moves the client should prioritize to strengthen its own competitive position.

Change We Created

Results You Can Quantify & Impact
Our Clients Can Count On

25%

Capability Expansion

With a clear list of priority CMOs and their various offerings, the client identified gaps in its portfolio and integrated nucleotide manufacturing capability, expanding the overall capacity by 25%.

20%

More Deals

Using the expanded portfolio, the client was able to ink 20% more deals with the expanded suite of offerings. This led to an improvement in the overall company footprint in the region with a wider access to different customers.

18%

Increase in RoI

By expanding offerings across nucleotides using existing infrastructure, the client was able to generate 18% more returns on the investment made annually. The additional returns were further channelized to increase manufacturing capacities